Life Biosciences has initiated human trials for its aging reversal treatments, marking a significant step in biotech. This 'reprogramming' approach could potentially transform how age-related diseases are treated. The implications for healthcare and longevity are profound, as successful outcomes may lead to broader applications in anti-aging therapies.